The goal of this award is to support the development of the candidate's skills to perform clinical research of affective and pharmacogenetic factors that influence stimulant abuse risk. Training will build upon the candidate's clinical psychology background in research on the association between affect and addiction. The career development plan consists of mentored training in stimulant psychopharmacology, the genetics of stimulant abuse, and affective mechanisms underlying addiction. The Brown University Center for Alcohol and Addiction Studies provides an intellectually stimulating environment with outstanding resources to ensure the candidate's successful achievement of his training plan. Dr. Christopher Kahler (primary mentor) and Drs. Harriet de Wit and Henry Kranzler (co-mentors) are each experts in affective mechanisms underlying addiction, stimulant psychopharmacology, and addiction genetics, respectively. The research plan will involve conducting an experimental pharmacogenetics laboratory study, which tests a putative model of stimulant abuse vulnerability that integrates affective and genetic sources of risk and is based on the notion that individual differences in the rewarding effects of drugs confer abuse liability. This model proposes that the influence of the dopamine transporter gene (a gene that regulates a key site of action for stimulants) on amphetamine's acute reinforcing effects is mediated by individual differences in hedonic capacity (a personality trait related to the ability to experience pleasure). Hypotheses derived from this model will be tested using a two-session double-blind within-subjects design laboratory experiment comparing response to placebo vs. 20mg oral d-amphetamine in 108 healthy drug-naive participants. Genotype and hedonic capacity will be assessed prior to testing as predictors of drug response. Results of this investigation are expected to support the submission of an R01 application that will expand this model to other genetic and affective sources of stimulant abuse vulnerability. In sum, this award will provide the candidate the necessary expertise to develop an independent innovative research program that will generate findings that elucidate mechanisms underlying stimulant abuse risk and inform more effective preventative interventions.

Public Health Relevance

Stimulant abuse is a major public health epidemic with substantial societal costs. This project will elucidate how personality and genes concomitantly predispose individuals to stimulant abuse, which will have value for: (a) understanding which individuals are at greatest risk for stimulant abuse;and (b) developing more effective prevention treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08DA025041-01A1
Application #
7658377
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Caulder, Mark
Project Start
2009-08-01
Project End
2014-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
1
Fiscal Year
2009
Total Cost
$151,929
Indirect Cost
Name
University of Southern California
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Bello, Mariel S; Pang, Raina D; Chasson, Gregory S et al. (2017) Obsessive-compulsive symptoms and negative affect during tobacco withdrawal in a non-clinical sample of African American smokers. J Anxiety Disord 48:78-86
Pang, Raina D; Kirkpatrick, Matthew G; Goldenson, Nicholas I et al. (2016) Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures. Pharmacol Biochem Behav 144:73-7
Bello, Mariel S; Pang, Raina D; Cropsey, Karen L et al. (2016) Tobacco Withdrawal Amongst African American, Hispanic, and White Smokers. Nicotine Tob Res 18:1479-87
Goldenson, Nicholas I; Pang, Raina D; Leventhal, Adam M (2016) Associations between ADHD symptoms and smoking outcome expectancies in a non-clinical sample of daily cigarette smokers. Am J Addict 25:152-9
Kirkpatrick, Matthew G; Goldenson, Nicholas I; Kapadia, Nahel et al. (2016) Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl) 233:89-97
Aguirre, Claudia G; Bello, Mariel S; Andrabi, Nafeesa et al. (2016) Gender, Ethnicity, and Their Intersectionality in the Prediction of Smoking Outcome Expectancies in Regular Cigarette Smokers. Behav Modif 40:281-302
Leventhal, Adam M (2016) The Sociopharmacology of Tobacco Addiction: Implications for Understanding Health Disparities. Nicotine Tob Res 18:110-21
Leventhal, Adam M; Zvolensky, Michael J (2015) Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull 141:176-212
Zvolensky, Michael J; Farris, Samantha G; Leventhal, Adam M et al. (2015) Emotional disorders and smoking: relations to quit attempts and cessation strategies among treatment-seeking smokers. Addict Behav 40:126-31
Guillot, Casey R; Stone, Matthew D; Geary, Bree A et al. (2015) Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study. Hum Psychopharmacol 30:364-71

Showing the most recent 10 out of 66 publications